Literature DB >> 27813445

Do ginger-derived nanoparticles represent an attractive treatment strategy for inflammatory bowel diseases?

Mingzhen Zhang1, James F Collins2, Didier Merlin1,3.   

Abstract

Entities:  

Keywords:  colitis-associated cancer; ginger-derived nanoparticles; inflammatory bowel disease; natural drug delivery system; therapy

Mesh：

Year:  2016        PMID： 27813445      PMCID： PMC5561796          DOI： 10.2217/nnm-2016-0353

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN： 1743-5889            Impact factor:   5.307


× No keyword cloud information.
  16 in total

Review 1.  Nanotechnology in the treatment of inflammatory bowel diseases.

Authors:  Angelo Viscido; Annalisa Capannolo; Giovanni Latella; Renzo Caprilli; Giuseppe Frieri
Journal:  J Crohns Colitis       Date:  2014-03-28       Impact factor: 9.071

2.  Tracking the down-regulation of folate receptor-α in cancer cells through target specific delivery of quantum dots coupled with antisense oligonucleotide and targeted peptide.

Authors:  Ming-Zhen Zhang; Yong Yu; Rong-Na Yu; Min Wan; Rong-Ying Zhang; Yuan-Di Zhao
Journal:  Small       Date:  2013-07-05       Impact factor: 13.281

Review 3.  Inflammatory bowel disease: etiology and pathogenesis.

Authors:  C Fiocchi
Journal:  Gastroenterology       Date:  1998-07       Impact factor: 22.682

4.  Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis.

Authors:  Masayuki Fukata; Limin Shang; Rebeca Santaolalla; John Sotolongo; Cristhine Pastorini; Cecilia España; Ryan Ungaro; Noam Harpaz; Harry S Cooper; Greg Elson; Marie Kosco-Vilbois; Julia Zaias; Maria T Perez; Lloyd Mayer; Arunan S Vamadevan; Sergio A Lira; Maria T Abreu
Journal:  Inflamm Bowel Dis       Date:  2010-11-15       Impact factor: 5.325

5.  How will new and future therapies change our treatment of IBD?

Authors:  Sebastian Zundler; Markus F Neurath
Journal:  Expert Rev Clin Immunol       Date:  2015-11-11       Impact factor: 4.473

Review 6.  Innate immune mechanisms of colitis and colitis-associated colorectal cancer.

Authors:  Maya Saleh; Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

Review 7.  Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine.

Authors:  Emilie Viennois; Yuan Zhao; Didier Merlin
Journal:  Inflamm Bowel Dis       Date:  2015-10       Impact factor: 5.325

8.  Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy.

Authors:  Mingzhen Zhang; Bo Xiao; Huan Wang; Moon Kwon Han; Zhan Zhang; Emilie Viennois; Changlong Xu; Didier Merlin
Journal:  Mol Ther       Date:  2016-08-05       Impact factor: 11.454

9.  Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit.

Authors:  Baomei Wang; Xiaoying Zhuang; Zhong-Bin Deng; Hong Jiang; Jingyao Mu; Qilong Wang; Xiaoyu Xiang; Haixun Guo; Lifeng Zhang; Gerald Dryden; Jun Yan; Donald Miller; Huang-Ge Zhang
Journal:  Mol Ther       Date:  2013-08-13       Impact factor: 11.454

Review 10.  Ginger and its constituents: role in prevention and treatment of gastrointestinal cancer.

Authors:  Sahdeo Prasad; Amit K Tyagi
Journal:  Gastroenterol Res Pract       Date:  2015-03-08       Impact factor: 2.260
View more
  8 in total

1.  Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis.

Authors:  Mingzhen Zhang; Xiaoyu Wang; Moon Kwon Han; James F Collins; Didier Merlin
Journal:  Nanomedicine (Lond)       Date:  2017-06-30       Impact factor: 5.307

Review 2.  The Potentiality of Plant-Derived Nanovesicles in Human Health-A Comparison with Human Exosomes and Artificial Nanoparticles.

Authors:  Mariantonia Logozzi; Rossella Di Raimo; Davide Mizzoni; Stefano Fais
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

Review 3.  Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis.

Authors:  Mingzhen Zhang; Didier Merlin
Journal:  Inflamm Bowel Dis       Date:  2018-06-08       Impact factor: 5.325

4.  Oral Gavage of Ginger Nanoparticle-Derived Lipid Vectors Carrying Dmt1 siRNA Blunts Iron Loading in Murine Hereditary Hemochromatosis.

Authors:  Xiaoyu Wang; Mingzhen Zhang; Shireen R L Flores; Regina R Woloshun; Chunhua Yang; Liangjie Yin; Ping Xiang; Xiaodong Xu; Michael D Garrick; Sadasivan Vidyasagar; Didier Merlin; James F Collins
Journal:  Mol Ther       Date:  2019-01-12       Impact factor: 11.454

5.  Protective effect of 6-paradol in acetic acid-induced ulcerative colitis in rats.

Authors:  Misbahuddin Rafeeq; Hussam Aly Sayed Murad; Hossam Mohammed Abdallah; Ali M El-Halawany
Journal:  BMC Complement Med Ther       Date:  2021-01-13

6.  Characterization of anti-proliferative and anti-oxidant effects of nano-sized vesicles from Brassica oleracea L. (Broccoli).

Authors:  Md Niamat Hossain; Vincenzo De Leo; Rosanna Tamborra; Onofrio Laselva; Chiara Ingrosso; Valeria Daniello; Lucia Catucci; Ilario Losito; Francesco Sollitto; Domenico Loizzi; Massimo Conese; Sante Di Gioia
Journal:  Sci Rep       Date:  2022-08-23       Impact factor: 4.996

7.  Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.

Authors:  Mingzhen Zhang; Changlong Xu; Dandan Liu; Moon Kwon Han; Lixin Wang; Didier Merlin
Journal:  J Crohns Colitis       Date:  2018-01-24       Impact factor: 9.071

8.  Oral Administration of Ginger-Derived Lipid Nanoparticles and Dmt1 siRNA Potentiates the Effect of Dietary Iron Restriction and Mitigates Pre-Existing Iron Overload in Hamp KO Mice.

Authors:  Xiaoyu Wang; Mingzhen Zhang; Regina R Woloshun; Yang Yu; Jennifer K Lee; Shireen R L Flores; Didier Merlin; James F Collins
Journal:  Nutrients       Date:  2021-05-15       Impact factor: 5.717
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.